Status:
UNKNOWN
Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Parkinson Disease
Eligibility:
All Genders
Brief Summary
Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease. By patients with motor fluctuations, continuous dopaminergic delivery devices or deep brain stimulation are ju...
Eligibility Criteria
Inclusion
- patient with Parkinson's disease and motor fluctuations
- and indicated for a continuous dopaminergic delivery device or deep brain stimulation
Exclusion
- age \< 18 years
- refusal for the continuous dopaminergic delivery device or deep brain stimulation
- wake-promoting drugs intake
- refusal to participate
- legal protection
- uncontrolled sleep apnea
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04441697
Start Date
June 1 2020
End Date
June 1 2023
Last Update
August 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy University Hospital
Nancy, France, 54000